Literature DB >> 8251070

Recombinant human IL-6 expressed in E. coli undergoes selective N-terminal degradation: evidence that the protein consists of a stable core and a nonessential flexible N-terminal.

A E Proudfoot1, S C Brown, A R Bernard, J Y Bonnefoy, E H Kawashima.   

Abstract

A synthetic gene for human interleukin-6 has been expressed in E. coli. The protein has been purified and renatured and has the same activity as natural human IL-6 using the 7TD1 cell proliferation assay. The protein undergoes specific cleavage by a thiol protease, yielding two new N-termini at Arg-9 and His-15. The truncated proteins retain full biological activity. The degradation results in the loss of sharp amide resonances in the 1H-NMR spectrum, and little change to the ultraviolet CD spectrum. Several amino acid type assignments could be made for these sharp amides using a DQF-COSY 2D-NMR experiment. The N-terminal 15 amino acids exist as a flexible, random coil, attached to a central structure.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8251070     DOI: 10.1007/bf01025050

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  26 in total

1.  Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.

Authors:  J Gauldie; C Richards; D Harnish; P Lansdorp; H Baumann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

2.  Identification of alpha 2-macroglobulin as a carrier protein for IL-6.

Authors:  T Matsuda; T Hirano; S Nagasawa; T Kishimoto
Journal:  J Immunol       Date:  1989-01-01       Impact factor: 5.422

3.  Dynamic filtering by two-dimensional 1H NMR with application to phage lambda repressor.

Authors:  M A Weiss; J L Eliason; D J States
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

4.  Molecular cloning and expression of hybridoma growth factor in Escherichia coli.

Authors:  J P Brakenhoff; E R de Groot; R F Evers; H Pannekoek; L A Aarden
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

5.  Disulfide structures of human interleukin-6 are similar to those of human granulocyte colony stimulating factor.

Authors:  C L Clogston; T C Boone; B C Crandall; E A Mendiaz; H S Lu
Journal:  Arch Biochem Biophys       Date:  1989-07       Impact factor: 4.013

6.  Chemical modification and 1H-NMR studies on the receptor-binding region of human interleukin 6.

Authors:  C Nishimura; T Ekida; S Masuda; K Futatsugi; S Itoh; K Yasukawa; T Kishimoto; Y Arata
Journal:  Eur J Biochem       Date:  1991-03-14

7.  Structure-function analysis of human interleukin-6. Evidence for the involvement of the carboxy-terminus in function.

Authors:  A Krüttgen; S Rose-John; C Möller; B Wroblowski; A Wollmer; J Müllberg; T Hirano; T Kishimoto; P C Heinrich
Journal:  FEBS Lett       Date:  1990-03-26       Impact factor: 4.124

8.  Modulation of polyamine biosynthesis and transport by oncogene transfection.

Authors:  B K Chang; P R Libby; R J Bergeron; C W Porter
Journal:  Biochem Biophys Res Commun       Date:  1988-11-30       Impact factor: 3.575

9.  Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin.

Authors:  T Hirano; K Yasukawa; H Harada; T Taga; Y Watanabe; T Matsuda; S Kashiwamura; K Nakajima; K Koyama; A Iwamatsu
Journal:  Nature       Date:  1986 Nov 6-12       Impact factor: 49.962

10.  High-level expression of human BSF-2/IL-6 cDNA in Escherichia coli using a new type of expression-preparation system.

Authors:  N Tonouchi; N Oouchi; N Kashima; M Kawai; K Nagase; A Okano; H Matsui; K Yamada; T Hirano; T Kishimoto
Journal:  J Biochem       Date:  1988-07       Impact factor: 3.387

View more
  4 in total

Review 1.  Interleukin-6: structure-function relationships.

Authors:  R J Simpson; A Hammacher; D K Smith; J M Matthews; L D Ward
Journal:  Protein Sci       Date:  1997-05       Impact factor: 6.725

2.  In vitro and in vivo antitumor effects of the recombinant immunotoxin IL6(T23)-PE38KDEL in multiple myeloma.

Authors:  DE-Jun Guo; Jia-Shan Han; Yan-Song Li; Zeng-Shan Liu; Shi-Ying Lu; Hong-Lin Ren
Journal:  Oncol Lett       Date:  2012-05-25       Impact factor: 2.967

3.  Influence of an established acute phase response on the severity of experimental nephritis.

Authors:  A M Karkar; A J Rees
Journal:  Clin Exp Immunol       Date:  1994-11       Impact factor: 4.330

4.  Application of a wide-range yeast vector (CoMed) system to recombinant protein production in dimorphic Arxula adeninivorans, methylotrophic Hansenula polymorpha and other yeasts.

Authors:  Gerhard Steinborn; Erik Böer; Anja Scholz; Kristina Tag; Gotthard Kunze; Gerd Gellissen
Journal:  Microb Cell Fact       Date:  2006-11-14       Impact factor: 5.328

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.